1. Market Research
  2. > Argentina Pharmaceuticals and Healthcare Report Q1 2017

Argentina Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 104 pages

Includes 3 FREE quarterly updates


>BMI View:
Argentina will present significant opportunities to multinational drugmakers over the next 10 years although short-term challenges owing to high inflation and drug price freezes will keep a lid on consumption and weigh on revenue potential. Despite an increase in generic medicine sales in volume terms, an upcoming amendment to medicine legislation will dampen generic medicine's market share of the overall pharmaceuticals matrix and pose challenges to branded generic medicine manufacturers in particular.

Meanwhile, recent improvement to Argentina's intellectual property regulatory framework poses upside risk to our forecast for innovative drugs and reflect the government's continued efforts to improve the business environment.

Headline Expenditure Projections Pharmaceuticals: ARS64.02bn (USD6.91bn) in 2015 to ARS80.27bn (USD5.43bn) in 2016; +25.4% in local currency terms and -21.4% in US dollar terms. Forecast revised slightly upward in local currency terms and slightly downward in US dollar terms from last quarter. Healthcare: ARS256.79bn (USD27.72bn) in 2015 to ARS336.05bn (USD22.74bn) in 2016; +30.9% in local currency terms and -18.0% in US dollar terms. Forecast revised upwards from last quarter.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceutical and Healthcare Forecasts (2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 22
Patented Drug Market Forecast 23
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 25
Generic Drug Market Forecast 26
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 28
OTC Medicine Market Forecast 29
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2012-2020) 31
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Argentina 2014-2020) 34
Table: Pharmaceutical Trade Data And Forecasts local currency (Argentina 2014-2020) 35
Industry Risk Reward Index 36
Americas Risk/Reward Index 36
Argentina Risk/Reward Index 40
Rewards 41
Risks 42
Regulatory Review 43
Table: Product Registration, Annex I and II Listed Countries 44
Intellectual Property Issues 50
Pricing Regime 57
Table: Pharmaceutical Price Build-Up 58
Reimbursement Regime 58
Market Overview 59
Healthcare Sector 60
Table: Healthcare Resources (Argentina 2010-2015) 63
Table: Healthcare Personnel (Argentina 2010-2015) 63
Table: Healthcare Activity (Argentina 2010-2015) 64
Research and Development 64
Clinical Trials 68
Epidemiology 69
Competitive Landscape 71
Research-Based Industry 72
Table: Multinational Market Activity 75
Generic Drugmakers 76
Pharmaceutical Distribution 78
Pharmaceutical Retail Sector 79
Company Profile 82
GlaxoSmithKline 82
Laboratorios Bago 84
Novartis 87
Sanofi 90
Demographic Forecast 93
Demographic Outlook 93
Table: Population Headline Indicators (Argentina 1990-2025) 94
Table: Key Population Ratios (Argentina 1990-2025) 94
Table: Urban/Rural Population and Life Expectancy (Argentina 1990-2025) 95
Table: Population By Age Group (Argentina 1990-2025) 95
Table: Population By Age Group % (Argentina 1990-2025) 96
Glossary 98
Methodology 100
Pharmaceutical Expenditure Forecast Model 100
Healthcare Expenditure Forecast Model 100
Notes On Methodology 101
Risk/Reward Index Methodology 102
Index Overview 103
Table: Pharmaceutical Risk/Reward Index Indicators 103
Indicator Weightings 104

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.